Ozempic®
Brand Name: Ozempic®
Composition: Semaglutide (Available in 0.25mg/0.5mg, and 1mg strengths)
Manufacturer: Novo
Product Description
Medical Info
Ozempic® is an advanced prescription biologic containing Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA). Developed by Novo Nordisk, this injectable therapy is primarily indicated for adults diagnosed with type 2 diabetes mellitus to significantly improve glycemic control alongside diet and exercise. By mimicking natural metabolic hormones, it effectively stimulates glucose-dependent insulin secretion, slows gastric emptying, and reduces glucagon levels.Additionally, Ozempic® is clinically proven to reduce the risk of major adverse cardiovascular events—such as heart attacks or strokes—in patients with type 2 diabetes and established cardiovascular disease. Administered via a pre-filled pen format once weekly for subcutaneous use, it represents a standard in modern chronic metabolic disease management
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
